U.S. Oil and Gas Stock News

Why American Bitcoin is on investors’ radar American Bitcoin (ABTC) has drawn attention after recent trading, with the share price at US$1.91 and value metrics such as a value score of 4 and an intrinsic discount of 36.0% now in focus. See our latest analysis for American Bitcoin. Recent trading has been choppy, with a 12.35% 7 day share price return sitting alongside a 5.45% 30 day decline and a much steeper 70.84% 90 day share price pullback. This suggests momentum has been fading despite...

On 6 January 2026, Zai Lab announced that China’s National Medical Products Administration approved a supplemental New Drug Application for AUGTYRO (repotrectinib) to treat adult patients with NTRK gene fusion solid tumors that are locally advanced or metastatic, or unsuitable for surgery, including those previously treated with TRK TKIs. This decision makes AUGTYRO the first therapy in China approved across both TRK TKI-naive and TRK TKI-pretreated solid tumor patients, potentially...

Event context and recent performance snapshot A. O. Smith (AOS) stock has drawn fresh attention after recent trading left the shares around $67.12, with returns roughly flat over the past month and a modest decline over the past 3 months. See our latest analysis for A. O. Smith. Zooming out, the 1 year total shareholder return is roughly flat at a 0.26% decline. The 3 and 5 year total shareholder returns of 13.28% and 25.95% suggest longer term holders have still seen gains even as recent...

AAR Corp. (AIR) has reported results for Q2 2026, with revenue of US$795.3 million and basic EPS of US$0.92, alongside trailing twelve month EPS of US$2.59 and net income of US$94.1 million. The company’s revenue has increased from US$686.1 million in Q2 2025 to US$795.3 million in Q2 2026, while quarterly EPS has moved from a loss of US$0.87 to a profit of US$0.92. This represents a very large year-over-year earnings improvement that feeds into forecasts calling for about 34.7% annual...

GSK and Ionis Pharmaceuticals recently reported that their experimental hepatitis B therapy bepirovirsen met primary endpoints in two Phase 3 trials, achieving a statistically significant and clinically meaningful functional cure rate and supporting planned global regulatory filings. The success of bepirovirsen not only adds a potentially first-in-class hepatitis B treatment to Ionis’s RNA-based portfolio, it also activates up to US$150,000,000 in potential milestones plus tiered royalties...

Textron Aviation, a unit of Textron Inc., announced that Prent Corporation will serve as Dove 1 for the 2026 Special Olympics Airlift arrivals, leading the nationwide mission to fly athletes and coaches into St. Paul Downtown Airport Holman Field on June 19, 2026. This high-profile community initiative, alongside investor focus on Textron’s upcoming fourth quarter 2025 earnings release and outlook call, is drawing renewed attention to how the company balances aviation, defense, and...

Multiple law firms have launched securities class action lawsuits against Bitdeer Technologies Group (BTDR), focusing on alleged misstatements around its SEALMINER A4 rigs and SEAL04 chip, following earnings misses and operational setbacks. See our latest analysis for Bitdeer Technologies Group. At a share price of $11.50, Bitdeer’s recent 7 day share price return of 2.59% contrasts with a 90 day share price return decline of 43.93%. Meanwhile, the 1 year total shareholder return decline of...

Wondering if Flagstar Bank National Association at US$12.55 offers good value today, or if the recent run has already priced in the key positives? The stock has been fairly flat year to date at 0.0%, but that sits alongside a 38.1% return over the last year and longer term moves of a 51.1% decline over three years and a 52.9% decline over five years. Recent coverage has focused on Flagstar's position as a regional banking name and how investors are reassessing risk across the sector. This...

Wondering whether Protagonist Therapeutics at around US$82 per share is still offering value, or if the best part of the opportunity has passed? This article is aimed at helping you frame that question clearly. The stock has been volatile in the short term, with a 5.8% decline over the last week and an 8.9% decline over the last month, even though the 1 year return stands at 118.6% and the 5 year return at 285.6%. These sharp moves come against a backdrop of ongoing interest in Protagonist...

W. R. Berkley (WRB) is back on investors’ radar after major shareholder Mitsui Sumitomo bought a large block of shares, lifting its stake materially and drawing attention to the insurer’s valuation and upcoming catalysts. See our latest analysis for W. R. Berkley. The recent insider buying comes after a mixed stretch for W. R. Berkley’s share price. The 30 day share price return of 2.82% has been offset by a 90 day decline of 11.65%, while the 1 year total shareholder return of 21.05%...

If you are wondering whether Fastly's current share price lines up with its underlying worth, or if the market is missing something, this article is for you. Fastly shares last closed at US$10.53, with returns of 3.4% over 7 days, a 5.3% decline over 30 days, 3.3% year to date, 11.8% over 1 year, 13.7% over 3 years and an 88.4% decline over 5 years. Recent coverage of Fastly has focused on how investors are reassessing content delivery and edge computing providers as the sector matures and...

What recent returns say about Palantir Technologies (PLTR) With no single headline event driving Palantir Technologies (PLTR) lately, investors are instead weighing its mixed share performance. This includes a roughly 1% move over the past month and a modest decline over the past 3 months. See our latest analysis for Palantir Technologies. Over the past year, Palantir Technologies has paired an 8.23% year to date share price return with a very large 1 year total shareholder return of 166.28%,...

Hycroft Mining Holding (HYMC) is back on traders’ screens after reporting its highest silver grades to date at the Vortex Silver System in Nevada, alongside a larger ownership stake from billionaire investor Eric Sprott. See our latest analysis for Hycroft Mining Holding. The recent drilling update and Eric Sprott’s higher stake arrive after a sharp shift in sentiment, with a 163.65% 30 day share price return, a 293.91% 90 day share price return, and a very large 1 year total shareholder...

Core & Main (CNM) is back on investor radar after analysts broadly raised their earnings estimates, a shift that often signals changing expectations for how a company’s near term financial results could look. See our latest analysis for Core & Main. At a share price of $53.25, Core & Main has had a mixed year, with recent 30 day and 90 day share price returns of 5.40% and 4.39%, alongside a modest 1 year total shareholder return of 4.04% and a very large 3 year total shareholder return that...

In recent days, analysts have become more optimistic on First Interstate BancSystem, with UBS and others reaffirming Hold views while highlighting improving loan growth, balance sheet trajectory, and disciplined execution ahead of the bank’s late-January 2026 fourth-quarter earnings release and investor call. At the same time, a significant shareholder trimmed their position and the stock’s trading has stayed muted, underscoring how investors are waiting for clearer signals on interest...

In early January 2026, Mobileye announced that a major U.S.-based automaker will use its EyeQ6H chip to power Surround ADAS hands-free driving systems as standard on millions of mainstream and premium vehicles worldwide. The deal lifts Mobileye’s estimated future EyeQ6H Surround ADAS deliveries to more than 19 million units, underlining how software-defined, single-chip architectures are increasingly central to automakers’ next-generation safety and automation plans. We’ll now examine how...

Photronics (PLAB) recently drew investor attention after its shares rose 5.4% in afternoon trading, following more optimistic earnings expectations and supportive news across the semiconductor sector, including stronger revenue guidance from peer Microchip Technology. See our latest analysis for Photronics. Those upbeat earnings expectations sit against a share price of $34.86 and a strong recent run, with a 30-day share price return of 38.06% and a 1-year total shareholder return of 43.93%...

If you are wondering whether Ascendis Pharma's current share price fairly reflects its prospects, you are not alone. Many investors are asking the same question right now. The stock recently closed at US$213.28, with returns of 0.0% over 7 days, 3.0% over 30 days, 0.0% year to date and 58.7% over 1 year, while the 3 year and 5 year returns stand at 87.7% and 28.9% respectively. Recent coverage has focused on Ascendis Pharma's progress and market position in pharmaceuticals and biotech. This...

If you are wondering whether Indivior at around US$35.89 still offers value after a strong run, this article will walk through what the current price might be implying about the company. The stock has delivered a 196.9% return over the last year and a 414.6% return over five years, although the last 30 days saw a 1.9% decline and the last week was flat. Investors have been reacting to ongoing news flow around the company and its position in the pharmaceutical and biotech space, which...

If you are wondering whether KLA's share price still reflects fair value after a strong run, this breakdown will help you see what the current market price might be pricing in. With the stock at US$1,359.69 and reported returns of 11.9% over 7 days, 11.0% over 30 days, 6.7% year to date, 99.8% over 1 year, 234.1% over 3 years and 394.6% over 5 years, many investors are asking what kind of valuation justifies those numbers. Recent coverage has focused on KLA's position in semiconductor...

If you are wondering whether Stanley Black & Decker is offering fair value at around US$78.69, you are not alone. This article is here to break that question into clear, practical pieces. The stock has returned 5.9% over the last 7 days, 8.7% over the last 30 days, 2.9% year to date and 1.0% over the last year, while the 3 year return is 3.2% and the 5 year return reflects a 46.5% decline. Recent coverage has focused on how investors are reassessing long term expectations for tool and...

If you are wondering whether Walt Disney's current share price is a fair deal or not, this article will walk through what the numbers are actually saying about the stock. The shares last closed at US$112.91, with returns of 4.9% over 30 days, 0.9% year to date and 4.0% over 1 year, while the 3 year return is 20.0% and the 5 year return is a 34.4% decline. Recent headlines around Disney have focused on its ongoing efforts to reshape its media and entertainment businesses, including content...

If you are wondering whether Incyte shares still offer value at current levels, you are not alone. This article is designed to walk you through that question step by step. Incyte's share price closed at US$110.57 recently, with total returns of 11.9% over 7 days, 14.3% over 30 days, 9.0% year to date, 51.2% over 1 year, 38.8% over 3 years and 19.2% over 5 years. This naturally raises questions about what is already priced in. Recent news around Incyte has focused on its position in the...

In recent days, Galaxy Digital has seen a jump in trading activity as investors refocused on crypto-related firms amid a recovering Bitcoin market. This renewed attention underscores how closely Galaxy’s diversified digital-asset operations are tied to shifts in broader crypto sentiment and volatility. We’ll now explore how this renewed trading interest, tied to Bitcoin’s recovery, might influence Galaxy Digital’s existing investment narrative. Trump's oil boom is here - pipelines are...